Colorado-based Enveda, which uses AI to find drug candidates, raised $130M, after raising $55M in June, and launches a clinical trial for an oral eczema drug (Sarah McBride/Bloomberg)
Sarah McBride / Bloomberg: Colorado-based Enveda, which uses AI to find drug candidates, raised $130M, after raising $55M in June, and launches a clinical trial for an oral eczema drug — AI has so far failed to transform health care, but investors are betting on its potential. — Enveda Therapeutics Inc. …
Sarah McBride / Bloomberg:
Colorado-based Enveda, which uses AI to find drug candidates, raised $130M, after raising $55M in June, and launches a clinical trial for an oral eczema drug — AI has so far failed to transform health care, but investors are betting on its potential. — Enveda Therapeutics Inc. …
This article has been sourced from various publicly available news platforms around the world. All intellectual property rights remain with the original publishers and authors. Unshared News does not claim ownership of the content and provides it solely for informational and educational purposes voluntarily. If you are the rightful owner and believe this content has been used improperly, please contact us for prompt removal or correction.
/cdn.vox-cdn.com/uploads/chorus_asset/file/24037123/226282_Decoder_Ryan_Petersen_WJoel.jpg){kind=small}
